Carbamazepine

Product NDC
67877-798
11-digit product format
678770798
Labeler code
67877
Product ID
67877-798_f712b540-b6b2-4fc7-a7b4-38b3a8e51964
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Carbamazepine
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Labeler
Ascend Laboratories, LLC
Application
ANDA217277
Marketing category
ANDA
Marketing start
2025-11-01
Substance
CARBAMAZEPINE
Active strength
200 mg/1
Pharmacologic classes
Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
33CM23913MCARBAMAZEPINE298-46-4CARBAMAZEPINE

Packages

Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
67877-798-0167877079801100 TABLET, EXTENDED RELEASE in 1 BOTTLE (67877-798-01) 2025-11-01NoNoHistorical
67877-798-0567877079805500 TABLET, EXTENDED RELEASE in 1 BOTTLE (67877-798-05) 2025-11-01NoNoHistorical
67877-798-306787707983030 TABLET, EXTENDED RELEASE in 1 BOTTLE (67877-798-30) 2025-11-01NoNoHistorical
67877-798-33678770798331 BLISTER PACK in 1 CARTON (67877-798-33) / 8 TABLET, EXTENDED RELEASE in 1 BLISTER PACK1 blister pack2025-11-01NoNoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
CarbamazepineAscend Laboratories, LLC | Alkem Laboratories Limited2025-11-03Human Prescription Drug Label5